DE1643022B2 - Verfahren zur herstellung von 21- estern der 11 alpha, 21-dihydroxysteroide mit einem verzweigtkettigen esterrest in 21-stellung sowie entsprechende 6 alpha-fluor-11 alpha-hydroxy-21-acyloxy- 16 alpha-methyl-1,4-pregnadien-3,20-dion- zwischenprodukte - Google Patents

Verfahren zur herstellung von 21- estern der 11 alpha, 21-dihydroxysteroide mit einem verzweigtkettigen esterrest in 21-stellung sowie entsprechende 6 alpha-fluor-11 alpha-hydroxy-21-acyloxy- 16 alpha-methyl-1,4-pregnadien-3,20-dion- zwischenprodukte

Info

Publication number
DE1643022B2
DE1643022B2 DE1967SC040711 DESC040711A DE1643022B2 DE 1643022 B2 DE1643022 B2 DE 1643022B2 DE 1967SC040711 DE1967SC040711 DE 1967SC040711 DE SC040711 A DESC040711 A DE SC040711A DE 1643022 B2 DE1643022 B2 DE 1643022B2
Authority
DE
Germany
Prior art keywords
alpha
hydroxy
acyloxy
branched
esterification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE1967SC040711
Other languages
German (de)
English (en)
Other versions
DE1643022A1 (de
Inventor
Heinz Dr.; Hader Josef Dr.; Bratfisch Gerhard Dr.; 1000 Berlin Gries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE1967SC040711 priority Critical patent/DE1643022B2/de
Priority to DE19681668691 priority patent/DE1668691A1/de
Priority to DK197568AA priority patent/DK127384B/da
Priority to CH659868A priority patent/CH517085A/de
Priority to AT454868A priority patent/AT312819B/de
Priority to SE06368/68A priority patent/SE351631B/xx
Priority to NO01818/68A priority patent/NO129678B/no
Priority to ES353766A priority patent/ES353766A1/es
Priority to FR1561884D priority patent/FR1561884A/fr
Priority to IT16380/68A priority patent/IT1047870B/it
Priority to NL6806774.A priority patent/NL159992C/xx
Priority to JP43031842A priority patent/JPS5141634B1/ja
Priority to BE715064D priority patent/BE715064A/xx
Publication of DE1643022A1 publication Critical patent/DE1643022A1/de
Publication of DE1643022B2 publication Critical patent/DE1643022B2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Gates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE1967SC040711 1967-05-13 1967-05-13 Verfahren zur herstellung von 21- estern der 11 alpha, 21-dihydroxysteroide mit einem verzweigtkettigen esterrest in 21-stellung sowie entsprechende 6 alpha-fluor-11 alpha-hydroxy-21-acyloxy- 16 alpha-methyl-1,4-pregnadien-3,20-dion- zwischenprodukte Granted DE1643022B2 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DE1967SC040711 DE1643022B2 (de) 1967-05-13 1967-05-13 Verfahren zur herstellung von 21- estern der 11 alpha, 21-dihydroxysteroide mit einem verzweigtkettigen esterrest in 21-stellung sowie entsprechende 6 alpha-fluor-11 alpha-hydroxy-21-acyloxy- 16 alpha-methyl-1,4-pregnadien-3,20-dion- zwischenprodukte
DE19681668691 DE1668691A1 (de) 1967-05-13 1968-03-12 Verfahren zur Herstellung von 21-Estern der 11alpha,21-Dihydroxysteroide
DK197568AA DK127384B (da) 1967-05-13 1968-04-29 Fremgangsmåde til fremstilling af 11α-hydroxy-21-acyloxy-steroider.
CH659868A CH517085A (de) 1967-05-13 1968-05-03 Verfahren zur Herstellung von 21-Estern der 11a,21-Dihydroxysteroide
AT454868A AT312819B (de) 1967-05-13 1968-05-10 Verfahren zur Herstellung von 11α-Hydroxy-21-acyloxysteroiden
SE06368/68A SE351631B (cs) 1967-05-13 1968-05-10
NO01818/68A NO129678B (cs) 1967-05-13 1968-05-10
ES353766A ES353766A1 (es) 1967-05-13 1968-05-10 Procedimiento de fabricacion de 11-alfahidroxi-21-aciloxi- esteroides.
FR1561884D FR1561884A (cs) 1967-05-13 1968-05-10
IT16380/68A IT1047870B (it) 1967-05-13 1968-05-11 Procedimento per preparare degli esteri in posizione 21 degli 11 21 diidrossisteroidi
NL6806774.A NL159992C (nl) 1967-05-13 1968-05-13 Werkwijze ter bereiding van 21-acyloxy-11alpha-hydroxy- -pregnaanderivaten.
JP43031842A JPS5141634B1 (cs) 1967-05-13 1968-05-13
BE715064D BE715064A (cs) 1967-05-13 1968-05-13

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1967SC040711 DE1643022B2 (de) 1967-05-13 1967-05-13 Verfahren zur herstellung von 21- estern der 11 alpha, 21-dihydroxysteroide mit einem verzweigtkettigen esterrest in 21-stellung sowie entsprechende 6 alpha-fluor-11 alpha-hydroxy-21-acyloxy- 16 alpha-methyl-1,4-pregnadien-3,20-dion- zwischenprodukte
DESC042090 1968-03-12

Publications (2)

Publication Number Publication Date
DE1643022A1 DE1643022A1 (de) 1971-01-21
DE1643022B2 true DE1643022B2 (de) 1976-12-30

Family

ID=25993465

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1967SC040711 Granted DE1643022B2 (de) 1967-05-13 1967-05-13 Verfahren zur herstellung von 21- estern der 11 alpha, 21-dihydroxysteroide mit einem verzweigtkettigen esterrest in 21-stellung sowie entsprechende 6 alpha-fluor-11 alpha-hydroxy-21-acyloxy- 16 alpha-methyl-1,4-pregnadien-3,20-dion- zwischenprodukte
DE19681668691 Pending DE1668691A1 (de) 1967-05-13 1968-03-12 Verfahren zur Herstellung von 21-Estern der 11alpha,21-Dihydroxysteroide

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19681668691 Pending DE1668691A1 (de) 1967-05-13 1968-03-12 Verfahren zur Herstellung von 21-Estern der 11alpha,21-Dihydroxysteroide

Country Status (12)

Country Link
JP (1) JPS5141634B1 (cs)
AT (1) AT312819B (cs)
BE (1) BE715064A (cs)
CH (1) CH517085A (cs)
DE (2) DE1643022B2 (cs)
DK (1) DK127384B (cs)
ES (1) ES353766A1 (cs)
FR (1) FR1561884A (cs)
IT (1) IT1047870B (cs)
NL (1) NL159992C (cs)
NO (1) NO129678B (cs)
SE (1) SE351631B (cs)

Also Published As

Publication number Publication date
NL159992C (nl) 1979-09-17
DE1643022A1 (de) 1971-01-21
AT312819B (de) 1974-01-25
DE1668691A1 (de) 1971-06-03
CH517085A (de) 1971-12-31
JPS5141634B1 (cs) 1976-11-11
NO129678B (cs) 1974-05-13
SE351631B (cs) 1972-12-04
FR1561884A (cs) 1969-03-28
BE715064A (cs) 1968-11-13
IT1047870B (it) 1980-10-20
ES353766A1 (es) 1970-02-01
NL6806774A (cs) 1968-11-14
DK127384B (da) 1973-10-29
NL159992B (nl) 1979-04-17

Similar Documents

Publication Publication Date Title
DE2526373C2 (de) Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden
DE1643022C3 (de) Verfahren zur Herstellung von 21- Estern der 11a, 21-Dihydroxysteroide mit einem verzweigtkettigen Esterrest in 21-Stellung sowie entsprechende 6 a-Fluor-11 a-hydroxy-21-acyloxy- 16 a-methyl-1,4pregnadien-3,20-dion- Zwischenprodukte
DE1643022B2 (de) Verfahren zur herstellung von 21- estern der 11 alpha, 21-dihydroxysteroide mit einem verzweigtkettigen esterrest in 21-stellung sowie entsprechende 6 alpha-fluor-11 alpha-hydroxy-21-acyloxy- 16 alpha-methyl-1,4-pregnadien-3,20-dion- zwischenprodukte
US2341081A (en) Compounds of the cyclopentanopolyhydrophenanthrene series and process for the manufacture thereof
DE1250821B (de) Verfahren zur Herstellung von 17a-Hydroxy-3-keto-/l4-pregnen-17-acylaten
DE1027663B (de) Verfahren zur Herstellung von in 12-Stellung unsubstituierten 11-Oxy-oder 11-Acyloxysteroiden
DE1618910A1 (de) Verfahren zur Veresterung von Cyclopentanophenanthrenderivaten
US2160719A (en) Pregnanolones and methods for producing the same from pregnandiols
DE1131213B (de) Verfahren zur Herstellung neuer Pregnanverbindungen
DE2644556C3 (de) Verfahren zur Herstellung von 17 a-Monoestern von 17 a, 21- Dihydroxysteroiden
AT334552B (de) Verfahren zur herstellung von neuen 18-methylensteroiden
AT231618B (de) Verfahren zur Herstellung von 1, 4, 9(11)-ungesättigten Verbindungen der Pregnanreihe
DE934703C (de) Verfahren zur Darstellung von 11-Monoestern des Sarmentogenins bzw. des 3-Dehydrosarmentogenins
AT239967B (de) Verfahren zur Herstellung von 18,20-Oxidosteroiden
CH553759A (de) Verfahren zur herstellung von neuen 4-chlor-1,2(alpha)-methylen-(delta)4,6-pregnadien-17(alpha)-ol-3,20-dion oder dessen 17estern.
AT250575B (de) Verfahren zur Herstellung neuer, therapeutisch wertvoller Carbonsäureester des 17 α-Äthinyl-19-nortestosterons
DE931529C (de) Verfahren zur Herstellung von in 7 (8)-Stellung ungesaettigten Androstanen
AT364098B (de) Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren
AT232654B (de) Verfahren zur Herstellung von 16α-Methyl-17α-hydroxy-20-ketonen der Allopregnan-Reihe
AT231084B (de) Verfahren zur Herstellung von in 1- und 4-Stellung ungesättigten Steroiden
CH537373A (de) Verfahren zur Herstellung neuer 7d-Methyl- 3,5--östradiene
CH351962A (de) Verfahren zur Herstellung 3,11,17-substituierter Steroide
CH532565A (de) Verfahren zur Herstellung von 9B,10a-Steroiden
CH402849A (de) Verfahren zur Herstellung von in 21-Stellung substituierten 16a-Methyl-allopregnanen
DE2114357A1 (de) Verfahren zur Herstellung von delta?-3-Keto-6a-alkyl-19-nor-steroiden

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
8339 Ceased/non-payment of the annual fee